14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ABVC vs ALPS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, ALPS (ALPS) captures the overall head-to-head institutional edge over ABVC BioPharma, Inc. (ABVC) on higher Unified Composite conviction (31.6/100 SELL vs. 47.4/100 HOLD) after splitting the core matrix 3–3 (led by Balance Sheet & Cash Flow), while ABVC wins 2–1 across the 6-pillar growth and valuation breakdown. ABVC trades at $0.87 (N/M Forward P/E, 0.0% operating margin) versus ALPS at $1.15 (N/M Forward P/E, 0.0% operating margin).
Composite vs. Pillar Nuance: While ABVC currently prints a higher short-term Unified Composite Score (47.4/100 HOLD vs. ALPS 31.6/100 SELL), ALPS captures the overall institutional head-to-head verdict (3–3 matrix metrics and 1–2 across the 6 pillars) due to superior fundamental profitability (0.0% vs. 0.0% operating margin) and revenue trajectory (+0.0% vs. +104.5% YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVC vs ALPS. Trailing 12-month operating profitability (ABVC 0.0% vs ALPS 0.0%) and valuation multiples (ABVC N/M vs ALPS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with $37.7M market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ ABVC vs ALPS Key Questions & Quantitative Answers
As of Nov 20, 2026, ALPS (ALPS) captures the overall head-to-head institutional edge over ABVC BioPharma, Inc. (ABVC) on higher Unified Composite conviction (31.6/100 SELL vs. 47.4/100 HOLD) after splitting the core matrix 3–3 (led by Balance Sheet & Cash Flow), while ABVC wins 2–1 across the 6-pillar growth and valuation breakdown. ABVC trades at $0.87 (N/M Forward P/E, 0.0% operating margin) versus ALPS at $1.15 (N/M Forward P/E, 0.0% operating margin). Composite vs. Pillar Nuance: While ABVC currently prints a higher short-term Unified Composite Score (47.4/100 HOLD vs. ALPS 31.6/100 SELL), ALPS captures the overall institutional head-to-head verdict (3–3 matrix metrics and 1–2 across the 6 pillars) due to superior fundamental profitability (0.0% vs. 0.0% operating margin) and revenue trajectory (+0.0% vs. +104.5% YoY).
ABVC leads the Growth & Scale pillar: ABVC posts +104.5% YoY revenue growth and +0.0% YoY earnings growth on $797,916 TTM revenue (100.0% gross margin, 0.0% operating margin), compared with ALPS at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, ABVC generates $797,916 in USD-normalized revenue versus N/A for ALPS. In operating R&D and SG&A reinvestment, ABVC deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ALPS.
ABVC screens cheaper on headline valuation multiples. ABVC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 29.9x EV/Revenue (unreported EBITDA margin), whereas ALPS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABVC (-52.7% ROE) versus ALPS (0.0% ROE) capital efficiency.
In options market volatility and institutional positioning, ABVC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.24β · 44% Vol realized risk). By comparison, ALPS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (6.25β · 1362% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.